Methadone in the Treatment of Chronic Nonmalignant Pain: A 2-Year Follow-up

Pain Medicine

Volumn 1, Issue 3, 2000, Pages 254-259

  Taylor, William F ^a   Finkel, Alan G ^a   Robertson, Kevin R ^a   Anderson, Abigail C ^a   Toomey, Timothy C ^a   Abashian, Sandra A ^a   Mann, J Douglas ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic Pain; Methadone; Nonmalignant Pain; Opioid

Indexed keywords

EID: 0005641964     PISSN: 15262375     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4637.2000.00027.x     Document Type: Article

References (46)

1. Finkel AG, Toomey TC, Abashian S, Mann JD. Methadone in chronic non-malignant pain: a retrospective study. The Pain Clinic 1998;10:235-43.
2. Clinical Practice Guideline: Acute Pain Management. U.S. Department of Health and Human Services. 1992;112-3.
3. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986;25:171-86.
4. Twycross RG, Lack SI. Symptom Control in Far Advanced Cancer: Pain Relief. London: Pitman, Bath; 1983.
5. Rayport M. Experience in the management of patients medically addicted to narcotics. JAMA 1954; 156:684-91.
6. Simpson DD, Savage LJ, Lloyd MR. Follow-up evaluation of treatment of drug abuse during 1969 to 1972. Arch Gen Psychiatry 1979;36:772-80.
7. McQuay HJ, Bullingham RES, Moore RA. Acute opiate tolerance in man. Life Sci 1981;28:2513-17.
8. Houde RW, Wallenstien SL, Beaver WT. Evaluation of analgesics in patients with cancer pain. In: Lasagna L, ed. International Encyclopedia of Pharmacology and Therapeutics, Section 6, Vol. 1. Clinical Pharmacology. Oxford: Pergamon; 1966:59-98.
9. Jasinki DS. Assessment of the abuse potentiality of the morphinelike drugs (methods used in man). In: Martin WR, ed. Handbook of Experimental Pharmacology. New York: Springer-Verlag; 1977:198-258.
10. Martin WR. General problems of drug abuse and dependence. In: Martin WR, ed. Handbook of Experimental Pharmacology. New York: Springer-Verlag; 1977:3-40.
11. Kleber H. The nosology of abuse and dependence. J Psychiatr Res 1990; 24(Suppl 2):57-64.
12. Galer BS, Coyle N, Pasternak GW, et al. Individual variability in the response to different opioids: report of 5 cases. Pain 1992;49:87-91.
13. Irick NE. Methadone: pluses and minuses. Indiana Med 1987;80:142-3.
14. Williamson PA, Foreman KJ, White JM, et al. Methadone-related overdose deaths in South Australia, 1984-1994. How safe is methadone prescribing? Med J Aust 1997;166:302-5.
15. Valliant GE. A 20-year follow-up of New York narcotic addicts. Arch Gen Psychiatry 1973;29:237-41.
16. Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage 1996;11:203-17.
17. American Academy of Pain Medicine, American Pain Society. The Use of Opioids for the Treatment of Chronic Pain. Glenview: American Academy of Pain Medicine and American Pain Society; 1997.
18. Sindrup SH, Brosen K, Bjerring P, et al. Codeine increases pain thresholds to copper laser stimuli but not in poor metabolizers of sparteine. Clin Pharmacol Ther 1990;48:686-93.
19. Portenoy RK. Opioid therapy for chronic nonmalignant pain: current status. In: Fields HL, Liebeskind JC, eds. Progress in Pain Research and Management, Vol 1. Pharmacological Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues. Seattle: IASP Press; 1994:247-87.
20. Sees KL, Clark HW. Opioid use in the treatment of chronic pain: assessment of addiction. J Pain Symptom Manage 1993;8:257-64.
21. Savage SR. Addiction in the treatment of pain: significance, recognition, and management. J Pain Symptom Manage 1993;8:265-78.
22. Jamison RN. Comprehensive pretreatment and outcome assessment for chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage 1996;11: 231-41.
23. Jarvik LF, Simpson JH, Guthrie D, et al. Morphine, experimental pain and psychological reactions. Psychopharmacology 1981;75:124-31.
24. Grove WM, Eckert ED, Heston L, et al. Heritability of substance abuse and antisocial behavior: a study of monozygotic twins reared apart. Biol Psychiatry 1990;27:1293-304.
25. Jaffe JH. Misinformation: euphoria and addiction. In: Hill CS, Fields W, eds. Advances in Pain Research and Therapy, Vol 11. New York: Raven; 1989:163-74.
26. Kaiko RF, Foley KM, Grabinski PY, et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1983;13:180-5.
27. Anthenelli RM, Schuckit MA. Genetics. In: Lowinson JH, Ruiz P, Millman RB, eds. Substance Abuse: A Comprehensive Textbook. Baltimore: Williams and Wilkins; 1992:39-50.
28. Cochin J, Kornetshy C. Development and loss of tolerance to morphine in the rat after single and multiple injections. J Pharmacol Exp Ther 1964;145:1-20.
29. Louie AL, Way EL. Overview of opiate tolerance and physical dependence. In: Almeida PF, Shippenburg TS, eds. Neurobiology of Opioids. New York: Springer-Verlag; 1991.
30. Foley KM. Clinical tolerance to opioids. In: Basbaum AI, Besson J-M, eds. Towards a New Pharmacotherapy of Pain. Chichester: John Wiley and Sons; 1991:181-203.
31. Foley KM. Changing concepts of tolerance to opioids: what the cancer patients have taught us. In: Current and Emerging Issues in Cancer Pain: Research and Practice. New York: Raven; 1993:331-50.
32. Portenoy RK. Opioid tolerance and efficacy: basic research and clinical observations. In: Gebhardt G, ed. Proceedings of the VIIth World Congress on Pain. Progress in Pain Research and Management, Vol 2. Seattle: IASP Press; 1994:595-619.
33. Schug SA, Zech D, Dorr U. Cancer pain management according to WHO analgesic guidelines. J Pain Symptom Manage 1990;5:27-32.
34. Hill CS. Relationship among cultural, educational and regulatory agency influence on optimum cancer pain treatment. J Pain Symptom Manage 1990; 5(Suppl):S37-S45.
35. France RD, Urban BJ, Keefe FJ. Long-term use of narcotic analgesics in chronic pain. Soc Sci Med 1984;19:1379-82.
36. Green J, Coyle M. Methadone use in the control of nonmalignant chronic pain. Pain Management 1989; Sept/Oct: 241-6.
37. Kell MJ, Musselman DL. Methadone prophylaxis of intractable headaches: pain control and serum opioid levels. AJPM 1993;3:7-14.
38. Urban BJ, France RD, Steinberger DL, et al. Long-term use of narcotic-depressant medication in the management of phantom limb pain. Pain 1986;24: 191-7.
39. Brescia FJ, Portenoy RK, Ryan M, et al. Pain, opioid use and survival in hospitalized patients with advanced cancer. J Clin Oncol 1992;10:149-55.
40. Kanner RM, Foley KM. Patterns of narcotic drug use in a cancer pain clinic. Ann NY Acad Sci 1981; 362:161-72.
41. Stenager EN, Stenager E. Suicide and patients with neurologic diseases. Methodologie problems. Arch Neurol 1992;49:1296-303.
42. Onofrio BM, Yaksh TL. Long-term pain relief produced by intrathecal morphine infusion in 53 patients. J Neurosurg 1990;72:200-9.
43. Kennedy JA, Crowley TJ. Chronic pain and substance abuse: a pilot study of opioid maintenance. J Substance Abuse Treat 1990;7:233-8.
44. Schofferman J. Long-term use of opioid analgesia for the treatment of chronic pain of nonmalignant origin. J Pain Symptom Manage 1993;8:279-88.
45. Jamison RN, Virts KL. The influence of family support on chronic pain. Behav Res Ther 1990;28: 283-7.
46. Jamison RN, Vasterling JJ, Parris WC. Use of sensory descriptors in assessing chronic pain patients. J Psychosom Res 1987;31:647-52.